Cite
APA Citation
Zhao, Y., Wang, X., Zhang, M., Liu, J., Pu, H., Li, X., Zhao, H., Xu, S., Yang, M., Bai, S., Guo, L., Zhao, L., Li, Y., & Wang, Y. (n.d.). 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172112399.0x000008